Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Midlands and North West
21 May 2013 18:45



Northern England
21 May 2013 18:03



National Team Build
21 May 2013 18:01


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
My Account Manager and their team at Zenopa have provided an excellent recruitment service while I was seeking a new position in the pharmaceutical sector.
Lowri, 2013

Final PIP implant verdict: Substandard but not toxic

20 June 2012 15:34 in Medical Government/ NHS related news


The government has published its final report into the performance of the heavily-criticised PIP breast implants, finding that the products are substandard but non-toxic.

Following an extensive global evidence review, an expert group led by NHS medical director Professor Sir Bruce Keogh has found that the implants do not contain any carcinogenic materials or anything that will pose a long-term health risk.

However, they do possess inferior mechanical strength that renders them twice as likely to rupture as other implants, which can cause local reactions among some patients.

Women with PIP implants have therefore been advised to speak to a surgeon about their options, with the NHS pledging to support any patients who choose to have their implants removed.

Professor Keogh said: "This has been an incredibly worrying time for women. We have been determined to look thoroughly at all available evidence so we are able to give them the best clinical advice possible."

The controversy surrounding PIP implants arose following the discovery that they utilise non-medical grade silicone, leading to a significantly increased rupture risk.ADNFCR-8000103-ID-801389327-ADNFCR

Other news stories from 20/06/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd